Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presents Q2 2022 financial results and provides a strategy update with 2027 long-term financial targets. The presentation discusses generic and specialty pharmaceutical business performance, including branded products such as AUSTEDO, AJOVY, and COPAXONE, alongside updates on opioid litigation matters.
earnings
37 Pages
earnings
49 Pages
Unknown
Alexion Pharmaceuticals Q2 2016 Earnings Call
earningsearnings
37 Pages
Alexion Pharmaceuticals
SITI Networks Q1 FY2020 Investor Presentation Results
earningsearnings
21 Pages
SITI Networks Limited